MeiraGTx Holdings (MGTX) Assets (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Assets came in at $244.4 million in Q4 2025, down 9.39% YoY from $269.8 million in Q4 2024, and up 29.01% on a QoQ basis from $189.5 million in Q3 2025.
MeiraGTx Holdings (MGTX) Assets (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Assets data on file, last reported at $244.4 million in Q4 2025.
- Quarterly Assets fell 9.39% year-over-year to $244.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $244.4 million (down 9.39% YoY) and the FY2025 annual result came in at $244.4 million, down 9.39% from the prior year.
- Assets advanced to $244.4 million in Q4 2025, from $189.5 million in the prior quarter.
- In the past five years, Assets ranged from a high of $326.7 million in Q4 2023 to a low of $1.7 million in Q1 2021.
- A 5-year average of $163.6 million and a median of $211.4 million in 2025 frame the typical range for Assets.
- Annual changes were most pronounced in 2021 — Assets soared 19724.4% — and 2023, when it plunged 68.13%.
- Tracing MGTX's Assets over 5 years: stood at $320.2 million in 2021, then retreated by 0.6% to $318.2 million in 2022, then advanced by 2.67% to $326.7 million in 2023, then slipped by 17.44% to $269.8 million in 2024, then decreased by 9.39% to $244.4 million in 2025.
- The last three Assets figures came in at $244.4 million (Q4 2025), $189.5 million (Q3 2025), and $198.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - | 244.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 244.43 Mn |
| Sep 30, 2025 | 189.47 Mn |
| Jun 30, 2025 | 198.72 Mn |
| Mar 31, 2025 | 224.01 Mn |
| Dec 31, 2024 | 269.75 Mn |
| Sep 30, 2024 | 299.49 Mn |
| Jun 30, 2024 | 266.65 Mn |
| Mar 31, 2024 | 309.24 Mn |
| Dec 31, 2023 | 326.74 Mn |
| Sep 30, 2023 | 267.19 Mn |
| Jun 30, 2023 | 2.39 Mn |
| Mar 31, 2023 | 3.16 Mn |
| Dec 31, 2022 | 318.24 Mn |
| Sep 30, 2022 | 7.60 Mn |
| Jun 30, 2022 | 7.48 Mn |
| Mar 31, 2022 | 8.57 Mn |
| Dec 31, 2021 | 320.16 Mn |
| Sep 30, 2021 | 4.03 Mn |
| Jun 30, 2021 | 3.18 Mn |
| Mar 31, 2021 | 1.71 Mn |